7 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular DiseaseSteno-occlusive DiseaseRecruitingPhase 32026-10-07NCT07348640
Gadopiclenol vs Gadoxetate MRI for Liver LesionsLiver LesionEnrolling by invitationNot stated2026-04-22NCT06596616
Guerbet Liver Fibrosismetabolic dysfunction-associated steatotic liver diseaseEnrolling by invitationNot stated2026-04-21NCT06703450
High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar AssessmentMyocardial FibrosisRecruitingPhase 42026-04-13NCT05954559
Developing MRI Technologies for Atrial FibrillationArrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorderEnrolling by invitationNot stated2026-03-23NCT07083115
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsDigestive System Diseases, Digestive System Neoplasms, Genital Diseases, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, breast disorder, breast neoplasm, carcinoma, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, hepatocellular carcinoma, intestinal disorder, liver disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, prostate cancer, prostate disorder, rectal disorder, skin disorderRecruitingPhase 42026-01-22NCT04373564
Lipiodol Prior to FET (LIFE)paroxysmal familial ventricular fibrillationNot yet recruitingNot applicable2024-08-21NCT06563908